Carmen Ianuli

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

P. Neven, F. Cardoso, L. Mauriac, 2010, Breast Cancer Research and Treatment.